Industry »Drug Manufacturers - General« (19)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
19 matches
| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | SAFETY | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
| LLY NYSE Eli Lilly |
Pharmaceuticals
Insulin, Diabetes Medications |
929B | 84 | 0.99 | 90 | 71 | 0.9% |
| JNJ NYSE Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
558B | 70 | 0.09 | 81 | 69 | 2.8% |
| ABBV NYSE AbbVie |
Biotechnology
Immunology Drugs, Oncology |
379B | 51 | -0.27 | 64 | 37 | 3.2% |
| AZN NASDAQ AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
290B | 59 | -0.73 | 66 | 46 | 1.8% |
| NVS NYSE Novartis |
Pharmaceuticals
Pharmaceuticals, Oncology |
290B | 60 | -0.34 | 69 | 62 | 3.1% |
| MRK NYSE Merck |
Pharmaceuticals
Oncology Drugs, Vaccines, Animal |
286B | 83 | 0.62 | 95 | 54 | 3.6% |
| NOV XETRA Novo Nordisk |
Biotechnology
Insulin, Weight Loss Drugs, Growth |
197B | 57 | -0.12 | 84 | 82 | 4.6% |
| NVO NYSE Novo Nordisk |
Pharmaceuticals
Insulin, Weight Loss, Growth |
197B | 49 | -0.32 | 84 | 26 | 4.7% |
| AMGN NASDAQ Amgen |
Biotechnology
Biopharmaceuticals, Oncology |
182B | 56 | -0.45 | 63 | 44 | 3.8% |
| GILD NASDAQ Gilead Sciences |
Biotechnology
Antivirals, Oncology, Cell |
162B | 66 | -0.27 | 79 | 45 | 2.7% |
| PFE NYSE Pfizer |
Pharmaceuticals
Vaccines, Oncology Drugs |
148B | 50 | -0.54 | 77 | 42 | 8.8% |
| BMY NYSE Bristol-Myers Squibb |
Pharmaceuticals
Oncology Drugs, Cardiovascular |
121B | 70 | -0.17 | 80 | 66 | 4.9% |
| GSK NYSE GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines, HIV |
103B | 62 | 0.08 | 65 | 53 | 4.9% |
| SAN PA Sanofi |
Pharmaceuticals
Vaccines, Pharmaceuticals |
103B | 49 | -0.46 | 77 | 69 | 9.9% |
| BAYN XETRA Bayer NA |
Pharmaceuticals
Prescription Medicines, Seeds |
44.8B | 56 | -0.22 | 75 | 70 | 0.3% |
| BIIB NASDAQ Biogen |
Biotechnology
Neurology Drugs, Multiple |
28.5B | 64 | -0.62 | 77 | 70 | - |
| REC MI Recordati Industria Chimica |
Pharmaceuticals
Rare Disease Drugs, Specialty |
12.0B | 59 | -0.16 | 74 | 42 | 4.0% |
| GRF MC Grifols S.A. |
Pharmaceuticals
Plasma Medicines, Diagnostic |
7.49B | 34 | -0.26 | 78 | 15 | 1.0% |
| OGN NYSE Organon |
Pharmaceuticals
Contraceptives, Biosimilars |
3.52B | 54 | 0.54 | 79 | 92 | 1.1% |
Technical
Structure
Fundamental
Topics in Industry »Drug Manufacturers - General« (19)
- Oncology
- Oncology Drugs
- Vaccines
- Insulin
- Immunology
- Pharmaceuticals
- Rare Diseases
- Cardiovascular Drugs
- Weight Loss Drugs
- Immunology Drugs
- Neuroscience
- Growth Hormones
- Biopharmaceuticals
- Specialty Medicines
- Biosimilars